| Circadian timing in cancer treatments F Lévi, A Okyar, S Dulong, PF Innominato, J Clairambault Annual review of pharmacology and toxicology 50, 377-421, 2010 | 459 | 2010 |
| Linear and non-linear analyses of heart rate variability: a minireview P Mansier, J Clairambault, N Charlotte, C Médigue, C Vermeiren, ... Cardiovascular research 31 (3), 371-379, 1996 | 191 | 1996 |
| Heart rate variability in normal sleeping full-term and preterm neonates J Clairambault, L Curzi-Dascalova, F Kauffmann, C Médigue, C Leffler Early Human Development 28 (2), 169-183, 1992 | 156 | 1992 |
| Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies A Lorz, T Lorenzi, ME Hochberg, J Clairambault, B Perthame ESAIM: Mathematical Modelling and Numerical Analysis-Modélisation …, 2013 | 148 | 2013 |
| Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation RH Chisholm, T Lorenzi, A Lorz, AK Larsen, LN Almeida, A Escargueil, ... Cancer research 75 (6), 930-939, 2015 | 135 | 2015 |
| Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors A Lorz, T Lorenzi, J Clairambault, A Escargueil, B Perthame Bulletin of mathematical biology 77 (1), 1-22, 2015 | 129 | 2015 |
| Decreased heart rate variability in transgenic mice overexpressing atrial beta 1-adrenoceptors P Mansier, C Medigue, N Charlotte, C Vermeiren, E Coraboeuf, ... American Journal of Physiology-Heart and Circulatory Physiology 271 (4 …, 1996 | 105 | 1996 |
| Heart-rate variability in low-risk prematurely born infants reaching normal term: a comparison with full-term newborns M Eiselt, L Curzi-Dascalova, J Clairambault, F Kauffmann, C Medigue, ... Early human development 32 (2-3), 183-195, 1993 | 100 | 1993 |
| Heart rate and heart rate variability during sleep in small-for-gestational age newborns L Spassov, L Curzi-Dascalova, J Clairambault, F Kauffmann, M Eiselt, ... Pediatric research 35 (4), 500-504, 1994 | 96 | 1994 |
| Cell population heterogeneity and evolution towards drug resistance in cancer: biological and mathematical assessment, theoretical treatment optimisation RH Chisholm, T Lorenzi, J Clairambault Biochimica et Biophysica Acta (BBA)-General Subjects 1860 (11), 2627-2645, 2016 | 90 | 2016 |
| Implications of circadian clocks for the rhythmic delivery of cancer therapeutics F Lévi, A Altinok, J Clairambault, A Goldbeter Philosophical Transactions of the Royal Society A: Mathematical, Physical …, 2008 | 90 | 2008 |
| The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate J Eliaš, L Dimitrio, J Clairambault, R Natalini Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1844 (1), 232-247, 2014 | 89 | 2014 |
| An age-and-cyclin-structured cell population model for healthy and tumoral tissues F Bekkal Brikci, J Clairambault, B Ribba, B Perthame Journal of mathematical biology 57, 91-110, 2008 | 89 | 2008 |
| Enabling multiscale modeling in systems medicine O Wolkenhauer, C Auffray, O Brass, J Clairambault, A Deutsch, D Drasdo, ... Genome medicine 6, 1-3, 2014 | 87 | 2014 |
| Applying ecological and evolutionary theory to cancer: a long and winding road F Thomas, D Fisher, P Fort, JP Marie, S Daoust, B Roche, C Grunau, ... Evolutionary Applications 6 (1), 1-10, 2013 | 74 | 2013 |
| Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations T Lorenzi, RH Chisholm, J Clairambault Biology direct 11 (1), 1-17, 2016 | 72 | 2016 |
| A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery A Ballesta, S Dulong, C Abbara, B Cohen, A Okyar, J Clairambault, F Levi PLoS computational biology 7 (9), e1002143, 2011 | 72 | 2011 |
| Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy C Pouchol, J Clairambault, A Lorz, E Trélat Journal de Mathématiques Pures et Appliquées 116, 268-308, 2018 | 71 | 2018 |
| Stability analysis of systems with distributed delays and application to hematopoietic cell maturation dynamics H Ozbay, C Bonnet, J Clairambault 2008 47th IEEE conference on decision and control, 2050-2055, 2008 | 61 | 2008 |
| Modelling physiological and pharmacological control on cell proliferation to optimise cancer treatments J Clairambault Mathematical Modelling of Natural Phenomena 4 (3), 12-67, 2009 | 59 | 2009 |
